DEFB109B
gene geneOn this page
Summary
DEFB109B (defensin beta 109B, HGNC:33469) is a protein-coding gene on chromosome 8p23.1, encoding Beta-defensin 109B (Q30KR1). Has antibacterial activity.
Predicted to enable CCR6 chemokine receptor binding activity and chemoattractant activity. Predicted to be involved in cell chemotaxis and defense response to bacterium. Predicted to be located in extracellular region. Predicted to be active in extracellular space.
Source: NCBI Gene 641517 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 2 total — 1 pathogenic
- MANE Select transcript:
NM_001037380
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33469 |
| Approved symbol | DEFB109B |
| Name | defensin beta 109B |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000206034 |
| Ensembl biotype | protein_coding |
| Entrez | 641517 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382656
RefSeq mRNA: 1 — MANE Select: NM_001037380
NM_001037380
Canonical transcript exons
ENST00000382656 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002060697 | 7319746 | 7320096 |
| ENSE00002079298 | 7312722 | 7312903 |
Expression profiles
Bgee: expression breadth broad, 84 present calls, max score 63.35.
Top tissues by expression
108 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 63.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 52.39 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 50.11 | gold quality |
| rectum | UBERON:0001052 | 47.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 44.42 | gold quality |
| granulocyte | CL:0000094 | 44.40 | silver quality |
| cortical plate | UBERON:0005343 | 43.42 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| calcaneal tendon | UBERON:0003701 | 36.33 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.33 | gold quality |
| muscle tissue | UBERON:0002385 | 34.66 | silver quality |
| bone marrow | UBERON:0002371 | 33.68 | silver quality |
| cortex of kidney | UBERON:0001225 | 33.03 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 32.47 | gold quality |
| urinary bladder | UBERON:0001255 | 32.41 | gold quality |
| duodenum | UBERON:0002114 | 32.33 | gold quality |
| placenta | UBERON:0001987 | 31.43 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 30.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.37 | gold quality |
| vermiform appendix | UBERON:0001154 | 30.22 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.61 | gold quality |
| fundus of stomach | UBERON:0001160 | 29.46 | gold quality |
| tonsil | UBERON:0002372 | 29.34 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.04 | gold quality |
| uterine cervix | UBERON:0000002 | 28.96 | silver quality |
| kidney | UBERON:0002113 | 28.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.29 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb48 | ENSMUSG00000075574 |
| rattus_norvegicus | Defb42 | ENSRNOG00000038762 |
Paralogs (6): DEFB4A (ENSG00000171711), DEFB4B (ENSG00000177257), DEFB109C (ENSG00000205989), DEFB130A (ENSG00000232948), DEFB130B (ENSG00000233050), DEFB109D (ENSG00000254866)
Protein
Protein identifiers
Beta-defensin 109B — Q30KR1 (reviewed: Q30KR1)
Alternative names: Defensin beta 109B
All UniProt accessions (1): Q30KR1
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Tissue specificity. Constitutively expressed in all regions of the ocular surface with predominant expression in the uppermost layers of the corneal epithelium and lower levels in basal layers (at protein level). Also detected in some keratocytes in the corneal stroma (at protein level). Expressed in all layers of the limbal epithelium with no expression found in limbal keratocytes (at protein level). Strongly expressed in the conjunctival epithelium with decreased expression in basal layers (at protein level). Also strongly expressed in tonsil tissue (at protein level).
Induction. Down-regulated on the ocular surface following inflammation and bacterial and viral infection.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001032457* (*=MANE)
Domains & families (InterPro)
UniProt features (5 total): disulfide bond 3, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q30KR1-F1 | 81.73 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 31–59, 38–53, 43–60
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
MSigDB gene sets: 23 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_CELL_CHEMOTAXIS, GOBP_TAXIS, GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_POSITIVE_CHEMOTAXIS, GOMF_CHEMOATTRACTANT_ACTIVITY, GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING, GOBP_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING, REACTOME_ANTIMICROBIAL_PEPTIDES, GOBP_LOCOMOTION, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS
GO Biological Process (4): defense response to bacterium (GO:0042742), cell chemotaxis (GO:0060326), defense response (GO:0006952), positive chemotaxis (GO:0050918)
GO Molecular Function (2): CCR6 chemokine receptor binding (GO:0031731), chemoattractant activity (GO:0042056)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chemotaxis | 2 |
| defense response | 1 |
| response to bacterium | 1 |
| cell migration | 1 |
| cellular response to chemical stimulus | 1 |
| response to stress | 1 |
| CCR chemokine receptor binding | 1 |
| receptor ligand activity | 1 |
| positive chemotaxis | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DEFB109B | CHST10 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H225, A4H227, A4H228, A4H238, A4H240, A4H253, A4H254, A4H255, A4H257, A4H258, A4H259, A4H262, A4H263, A4H264, A4H265, P0C8A8, P0DY26, P0DY27, Q29RT9, Q30KJ7, Q30KK0, Q30KK1, Q30KK9, Q30KL1, Q30KL7, Q30KP3, Q30KP5, Q30KQ4, Q30KQ5, Q30KQ8, Q30KR1, Q30KT5, Q32P86, Q32ZH2, Q32ZH6, Q3UW43
Diamond homologs: P0DP73, P0DP74, P0DY26, P0DY27, Q30KJ9, Q30KL7, Q30KR1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 4755349 | GRCh38/hg38 8p23.1(chr8:7296514-12636756)x1 | Pathogenic |
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000175733 (8:7315970 T>C), RS1000246538 (8:7307819 G>A), RS1000704437 (8:7315745 G>A,C), RS1000805630 (8:7308052 T>A,C), RS1001374306 (8:7311905 T>A,C), RS1001404474 (8:7319629 T>A,C), RS1002378946 (8:7313363 G>A), RS1002481931 (8:7310724 G>A,C,T), RS1002527772 (8:7310414 A>C,G,T), RS1003039750 (8:7309984 C>T), RS1003140426 (8:7318218 T>C), RS1003541137 (8:7312510 A>C,G), RS1004196868 (8:7309281 C>T), RS1004653924 (8:7308773 T>A,C), RS1004744988 (8:7316393 CT>C,CTT)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007565_164 | Morning person | 1.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.